ABCL - Abcellera Biologics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABCL is currently covered by 4 analysts with an average price target of $15.16. This is a potential upside of $10.69 (239.15%) from yesterday's end of day stock price of $4.47.

Abcellera Biologics 's activity chart (see below) currently has 43 price targets and 44 ratings on display. The stock rating distribution of ABCL is 76.47% BUY and 23.53% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.88% with an average time for these price targets to be met of 87.29 days.

Highest price target for ABCL is $10, Lowest price target is $5, average price target is $7.5.

Most recent stock forecast was given by SCOTT SCHOENHAUS from KEYBANK on 14-Jul-2025. First documented stock forecast 05-Jan-2021.

Best performing analysts who are covering ABCL - Abcellera Biologics :

Puneet Souda Scott Schoenhaus Do Kim Tiago Fauth Gary Nachman Andrea Tan Robert Wasserman

Currently out of the existing stock ratings of ABCL, 13 are a BUY (76.47%), 4 are a HOLD (23.53%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$5.78 (136.97%)

$5

1 months 29 days ago
(14-Jul-2025)

3/7 (42.86%)

$5.76 (135.85%)

217

Hold

6 months 9 days ago
(03-Mar-2025)

0/2 (0%)

$6.55 (120.18%)

Buy

$5

$0.78 (18.48%)

$22

10 months 7 days ago
(05-Nov-2024)

1/4 (25%)

$2.28 (83.82%)

258

Buy

$24

$19.78 (468.72%)

$30

2 years 1 months 8 days ago
(04-Aug-2023)

0/2 (0%)

$17.96 (297.35%)

Buy

$28

$23.78 (563.51%)

$34

2 years 4 months 7 days ago
(05-May-2023)

1/6 (16.67%)

$22.01 (367.45%)

24

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABCL (Abcellera Biologics ) average time for price targets to be met?

On average it took 87.29 days on average for the stock forecasts to be realized with a an average price target met ratio 18.88

Which analyst has the current highest performing score on ABCL (Abcellera Biologics ) with a proven track record?

PUNEET SOUDA

Which analyst has the current lower performing score on ABCL (Abcellera Biologics ) with a proven track record?

ROBERT WASSERMAN

Which analyst has the most public recommendations on ABCL (Abcellera Biologics )?

Puneet Souda works at LEERINK and has 13 price targets and 8 ratings on ABCL

Which analyst is the currently most bullish on ABCL (Abcellera Biologics )?

Tiago Fauth with highest potential upside - $23.78

Which analyst is the currently most reserved on ABCL (Abcellera Biologics )?

Robert Wasserman with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?